EORI Bulletin

02/08/2021 – 5-minute update

EORI keeps an eye on changes in the fields of Open Science, FAIR data principles, and others, and directs any interested parties to important updates:

  • Of significance, the European Research Council has banned grant applicants from including journal metrics when applying for grants (here). This is a welcome step forward for research being considered based on quality rather than where it’s been published. Hopefully we’ll see more of this from other funders.
  • Clinical trial data from many FDA-approved drugs are still not available (here); for 3/4 products, one or more relevant trial(s) are unavailable for independent inspection. Further, around 1/4 of these breached legal requirements. There are suggestions that the introduction of European-style legislation could help remedy this (here), and allow for relevant data to be accessible. 
  • This systematic review and meta-analysis of attempts to improve the peer review process of biomedical research. It neatly synthesises the results of various interventions, and may give us an idea of how the peer review process may change for the better in the future. 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s